M. Mahendran

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study

R. Ray, M. Duh, F. Laliberté, 2021, BMC Pulmonary Medicine.

Symptom control in patients with asthma using inhaled corticosteroids/long-acting β2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study

M. Duh, F. Laliberté, G. Germain, 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors

R. Ionescu-Ittu, N. Shore, M. Duh, 2021, Advances in Therapy.

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population

S. Krishnan, M. Duh, N. Mody-Patel, 2021, Advances in Therapy.

Real-World Racial Variation in Treatment and Outcomes Among Patients with Peripheral Artery Disease

K. Ferdinand, P. Lefebvre, F. Laliberté, 2023, Advances in Therapy.

Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.

R. Ionescu-Ittu, Jeri Kim, N. Shore, 2021, Clinical genitourinary cancer.

Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Observational Study

R. Vij, M. Duh, M. Hultcrantz, 2022, Blood.

Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study

P. Lefebvre, W. Cheng, M. Mahendran, 2023, BMC Neurology.

Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder.

F. Laliberté, G. Germain, M. Mahendran, 2023, Journal of managed care & specialty pharmacy.